Microbix Biosystems Inc. (MBX:TSX) Investor Relations Material

Overview

Microbix Biosystems Inc. is a Canadian company that specializes in the development of biological products and technologies. The company's primary focus is the production of infectious disease antigens for use in the diagnostics market. Microbix Biosystems Inc. is also investing heavily in the virology business to develop new products and address emerging market opportunities. The company's expertise in virology and protein biochemistry is key to its success in this industry. With a focus on enhancing its manufacturing and laboratory capabilities, Microbix Biosystems Inc. is well-positioned to continue to grow and thrive in this competitive market.

Frequently Asked Questions

What is Microbix Biosystems Inc.'s ticker?

Microbix Biosystems Inc.'s ticker is MBX

What exchange is Microbix Biosystems Inc. traded on?

The company's shares trade on the TSX stock exchange

Where are Microbix Biosystems Inc.'s headquarters?

They are based in Mississauga, Ontario

How many employees does Microbix Biosystems Inc. have?

There are 51-200 employees working at Microbix Biosystems Inc.

What is Microbix Biosystems Inc.'s website?

It is https://microbix.com/

What type of sector is Microbix Biosystems Inc.?

Microbix Biosystems Inc. is in the Healthcare sector

What type of industry is Microbix Biosystems Inc.?

Microbix Biosystems Inc. is in the Biotechnology industry

Who are Microbix Biosystems Inc.'s peers and competitors?

The following five companies are Microbix Biosystems Inc.'s industry peers:

- CSL

- Vitae

- Windtree Therapeutics, Inc.

- Bio-Gene Technology Limited

- Prothena Corp